In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

This was over 28 days in a phase 1 trial. The level of weight loss and the tolerability of the treatment at 100-milligram ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

In the quest for effective weight loss solutions, many individuals are turning to dietary supplements that promise to enhance ...

Amid growing concerns over counterfeit weight loss medications, a local clinical trial may offer a safer alternative for ...

The company's latest presentation supports the idea that its lead program will make billions.

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...

AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...